Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era |
| |
Authors: | Gi-Won Song Sung-Gyu Lee Shin Hwang Ki-Hum Kim Chul-Soo Ahn Deok-Bog Moon Tae-Yong Ha Dong-Hwan Jung Gil-Chun Park Sung-Hwa Kang Bo-Hyun Jung Young-In Yoon Nayoung Kim |
| |
Affiliation: | 1 Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Ulsan College of Medicine, Seoul, Republic of Korea;2 Asan Center for Life Science, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea |
| |
Abstract: | |
| |
Keywords: | AMR, antibody-mediated rejection ABOi, ABO-incompatible ALDLT, adult living donor liver transplantation RIT, rituximab BS, biliary stricture BD, bile duct IA, isoagglutinin CMV, cytomegalovirus DIHBS, diffuse intrahepatic biliary stricture LDLT, living donor liver transplantation CNI, calcineurin inhibitor ABOc, ABO-compatible DSZ, desensitization PE, plasma exchange LGIT, local graft infusion therapy CD20+, CD20 positive B lymphocyte LFT, liver function test CT, computed tomography MELD, model for end-stage liver disease ICU, intensive care unit BMI, body mass index IHM, in-hospital mortality BPACR, biopsy-proven acute cellular rejection ABOc, ABO compatible GRWR, graft-to-recipient weight ratio LT, liver transplantation RL, right lobe LL, left lobe BDO, bile duct opening BDA, bile duct anastomosis DD, duct-to-duct HJ, hepaticojejunostomy AST, Aspartate transferase ALT, alanine transferase |
本文献已被 ScienceDirect 等数据库收录! |
|